Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning - Jongilpoom brand Enoki Mushroom recalled due to Listeria monocytogenes


Product photos are available: https://inspection.canada.ca/eng/1631848956953/1631848962398

OTTAWA, ON, Sept. 16, 2021 /CNW/ - Covic International Trading Inc. is recalling Jongilpoom brand Enoki Mushroom from the marketplace due to possible Listeria monocytogenes contamination. Consumers should not consume the recalled product described below.

The following product has been sold in Alberta and British Columbia.

Recalled product

Brand

Product

Size

UPC

Codes

Jongilpoom

Enoki Mushroom

200 g

8 807076 000321

CE 158D

What you should do

If you think you became sick from consuming a recalled product, call your doctor.

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased.

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Background

This recall was triggered by Canadian Food Inspection Agency (CFIA) test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...

at 07:05
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its lead program in severe hemophilia A at the World...



News published on and distributed by: